ArticleStrahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]2026

Carboplatin/Paclitaxel can be an effective alternative for cisplatin-ineligible patients with locally advanced HNSCC.

Stefan Gravemeyer et al.PubMed ↗Publisher ↗

No numbers read from the abstract.